OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

224 GILD shares were withheld to cover taxes or exercise cost (Director) | OQRO

Home
Insider trades
Gilead Sciences
224 GILD shares were withheld to cover taxes or exercise cost (Directo

Insider trades

Insider trade

224 GILD shares were withheld to cover taxes or exercise cost (Director)

Traded Apr 30, 2026 · Filed May 4, 2026

GILGilead SciencesGILD

224
Shares · @ $130.84

Why it stands out

Routine share withholding; mechanical by default.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 30, 2026
Reporting period: Not applicable
Filed with the SEC: May 4, 2026

DirectorTax withholding

Context

Classification

tax withholding

Code F — shares delivered to pay exercise price or tax liability

Planned / mechanical clue

Tax mechanics (code F)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001527726-26-000002

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

May 4, 2026, 8:20 PM UTC

Added to OQRO

Oct 2, 2026, 12:27 PM UTC

Parser

form4-xml-v1

Data quality

Verified: identifiers matched exactly

Issuer

GILEAD SCIENCES, INC.

Issuer CIK

882095

Ticker

GILD

Reporting person

Harish Manwani

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Apr 30, 2026

Transaction code

Shares / units

224

Price per share

$130.84

Acquired / disposed

Disposed (D)

Shares owned after

15,015

Ownership form

Direct

Amendment

Around the same time

CEO sold ~$1.43M of Gilead Sciences

Scheduled in advance4mo ago

CEO sold ~$405K of Gilead Sciences

Scheduled in advance4mo ago

CEO sold ~$138K of Gilead Sciences

Scheduled in advance4mo ago